CA 19-9 as a predictor of response and survival in patients with pancreatic cancer treated with gemcitabine and cisplatin based chemotherapy

被引：0
|
作者：
Heilbrun, L. K.
Khanna, A.
Venkatramanamoorthy, R.
Shields, A. F.
Philip, P. A.
Zalupski, M. M.
El-Rayes, B. F.
机构：
[1] Karmanos Canc Inst, Detroit, MI USA
[2] Wayne State Univ, Detroit, MI USA
[3] Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15094
引用
收藏
页数：4
相关论文
共 50 条
  • [31] CA 19-9: A surrogate to assess response to treatment in patients with metastatic pancreatic cancer (MPC).
    Diaz, Celso L.
    Cinar, Pelin
    Hwang, Jimmy
    Ko, Andrew H.
    Tempero, Margaret A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] Black Race and CA 19-9 Nonproduction is Associated with Limited Pathologic Response to Neoadjuvant Chemotherapy in Patients with Localized Pancreatic Cancer
    Martos, Mary P.
    Dickey, Erin M.
    Yanala, Ujwal R.
    Abdilleh, Kawther
    Ogobuiro, Ifeanyichukwu
    Box, Edmond W.
    Ahmad, Syed A.
    Maithel, Shishir K.
    Hammill, Chet W.
    Kim, Hong J.
    Abbott, Daniel E.
    Kooby, David A.
    Parikh, Alexander A.
    Hosein, Peter J.
    Merchant, Nipun B.
    Datta, Jashodeep
    Hester, Caitlin A.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S167 - S168
  • [33] Black race and CA 19-9 nonproduction is associated with limited pathologic response to neoadjuvant chemotherapy in patients with localized pancreatic cancer
    Martos, Mary P.
    Dickey, Erin M.
    Abdilleh, Kawther
    Ahmad, Syed A.
    Maithel, Shishir K.
    Hammill, Chet W.
    Kim, Hong Jin
    Abbott, Daniel E.
    Kooby, David A.
    Parikh, Alexander A.
    Hosein, Peter J.
    Merchant, Nipun B.
    Datta, Jashodeep
    Hester, Caitlin A.
    CANCER RESEARCH, 2024, 84 (17)
  • [34] Prognostic value of CA 19-9 kinetics during gemcitabine-based chemotherapy in patients with advanced cholangiocarcinoma
    Lee, S. H.
    Lee, B. S.
    Ryu, J.
    Kim, Y. -T.
    ANNALS OF ONCOLOGY, 2015, 26
  • [35] Prognostic value of CA 19-9 kinetics during gemcitabine-based chemotherapy in patients with advanced cholangiocarcinoma
    Lee, Jae Woo
    Son, Jun Hyuk
    Lee, Ban Seok
    Lee, Sang Hyub
    Jang, Dong Kee
    Chung, Kwang Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    ANNALS OF ONCOLOGY, 2015, 26 : 121 - 121
  • [36] CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial
    Hess, Viviane
    Glimelius, Bengt
    Grawe, Philipp
    Dietrich, Daniel
    Bodoky, Gyoergy
    Ruhstaller, Thomas
    Bajetta, Emilio
    Saletti, Piercarlo
    Figer, Arie
    Scheithauer, Werner
    Herrmann, Richard
    LANCET ONCOLOGY, 2008, 9 (02): : 132 - 138
  • [37] Association of race and CA 19-9 nonproduction with limited pathologic response to neoadjuvant chemotherapy in patients with localized pancreatic cancer.
    Martos, Mary P.
    Dickey, Erin M.
    Yanala, Ujwal R.
    Abdilleh, Kawther
    Ogobuiro, Ifeanyichukwu
    Box, Edmond Worley
    Ahmad, Syed A.
    Maithel, Shishir K.
    Hammill, Chet W.
    Kim, Hong Jin Jin
    Abbott, Daniel Erik
    Kooby, David A.
    Parikh, Alexander A.
    Hosein, Peter Joel
    Merchant, Nipun B.
    Datta, Jashodeep
    Hester, Caitlin A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 609 - 609
  • [38] Prognostic value of CA 19-9 kinetics during gemcitabine-based chemotherapy in patients with advanced cholangiocarcinoma
    Lee, Ban Seok
    Lee, Sang Hyub
    Son, Jun Hyuk
    Jang, Dong Kee
    Chung, Kwang Hyun
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (02) : 493 - 500
  • [39] Is There any Survival Benefit of Maintenance Chemotherapy Following Adjuvant Chemotherapy in Patients with Resected Pancreatic Cancer Patients with Post-Surgery Elevated CA 19-9?
    Saif, Muhammad Wasif
    Smith, Melissa H.
    Goodman, Martin D.
    Salem, Ronald R.
    JOURNAL OF THE PANCREAS, 2020, 21 (05): : 118 - 124
  • [40] CA 19-9: Not a magic marker for pancreatic cancer
    Daram, Sumanth R.
    SOUTHERN MEDICAL JOURNAL, 2006, 99 (03) : 205 - 205
12345